ABSTRACT. We conducted a case-control study to investigate the association between the interleukin-10 (IL-10) C819T polymorphism and susceptibility to gastric cancer in a Chinese population. A total of 157 patients with gastric cancer and 249 controls were consecutively enrolled from the Guizhou Provincial People's Hospital between October 2012 and February 2015. The polymerase chain reactionrestriction fragment length polymorphism technique was used to genotype for IL-10 C819T. As determined by c 2 -test, there was a significant difference in genotype distributions of IL-10 C819T between gastric cancer patients and controls (c 2 = 7.09; P = 0.03). Based on unconditional logistic regression analysis, the TT genotype of IL-10 C819T was significantly associated with increased risk of gastric cancer when compared with that of the CC genotype [odds ratio (OR) = 2.24; 95% confidence interval (CI) = 1.17-4.26; P = 0.008]. In a dominant model, we found that the CT + TT genotype of IL-10 C819T was associated with susceptibility to gastric cancer compared to that of the CC genotype (OR = 1.63; 95%CI = 1.02-2.64). In a recessive model, the TT genotype of IL-10 C819T was correlated with a higher risk of gastric cancer when compared with that of the CC + CT genotype (OR = 1.75; 95%CI = 1.01-3.02). In conclusion, our study suggests that the IL-10 C819T polymorphism is associated with an increased risk of gastric cancer in co-dominant, dominant, and recessive models.
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INTRODUCTION
Gastric cancer is the fifth most common malignancy and the third leading cause of cancer death worldwide (International Agency for Research on Cancer, 2012). It is indicated that Helicobacter pylori infections are associated with susceptibility to gastric cancer (Figueiredo et al., 2015; Venerito et al., 2015) . However, the precise etiology of this cancer remains unclear. Many previous studies have reported that polymorphisms in inflammationrelated genes, such as tumor necrosis factor-alpha, toll-like receptors, and interleukins (IL), may be involved in the development of gastric cancer (Assis et al., 2014; Castaño-Rodríguez et al., 2014; Li et al., 2014; Qadri et al., 2014) .
IL-10 is a pleiotropic cytokine, and a wealth of evidence supports its regulatory role in carcinogenesis and tumor growth (Tanikawa et al., 2012; Holan et al., 2014; Qi et al., 2014; Yu et al., 2014) . There are several polymorphisms in the IL-10 gene, and IL-10 C819T (rs1800871) is a common single nucleotide polymorphism (SNP) in the promoter region. Many studies have reported the association between the IL-10 C819T gene polymorphism and development of gastric cancer, but the results are inconclusive (Kamangar et al., 2006; Sugimoto et al., 2007; Xiao et al., 2009; Sun et al., 2010; Liu et al., 2011; Xue et al., 2012; Zeng et al., 2012) . Therefore, we carried out a hospital-based case-control study to evaluate the correlation between the IL-10 C819T polymorphism and susceptibility to gastric cancer in a Chinese population.
MATERIAL AND METHODS

Patients
Samples from a total of 157 patients with gastric cancer were consecutively collected from the Gastrointestinal Department of Internal Medicine, Guizhou Provincial People's Hospital between October 2012 and February 2015. These patients received gastrointestinal endoscopy and were diagnosed independently by two pathologists.
Control samples were consecutively were collected from individuals who obtained regular health examinations. All control subjects received the gastrointestinal endoscopy and were confirmed to be free of gastric cancer by pathologists. All control subjects were free of cancers, digestive diseases, and serious kidney and liver diseases. Finally, a total of 249 subjects were recruited as controls.
The demographic, lifestyle, and clinical information were collected from medical records, including gender, age, family history of cancer, body mass index (BMI), tobacco smoking, alcohol consumption, tumor-node-metastasis (TNM) stage, Lauren classification, and presence of H. pylori infection. The H. pylori infection was determined by a rapid urea breath test.
Signed informed consent was obtained from each participant prior to joining this study, and the protocol was approved by the Ethics Committee of Guizhou Provincial People's Hospital.
DNA extraction and genotyping
Collected blood samples were stored in a tube with ethylene diamine tetraacetic acid and kept at -20°C until use. TIANamp Blood DNA Kit (Tiangen, Beijing, China) was used to perform DNA extraction. The polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique was used to genotype for the IL-10 C819T polymorphism. The forward and reverse primers of IL-10 C819T for PCR were 5'-TCATTCTATGTGCTGGAGATGG-3' and 5'-TGGGGGAAGTGGGTAAGAGT-3', respectively. The restriction enzyme for IL-10 C819T was MseI. The digested fragments for the C allele of IL-10 C819T were 93 and 116 bp, and the fragment for the T allele was 209 bp. The PCR consisted of: denaturation at 95°C for 5 min; 30 cycles of denaturation at 95°C for 30 s, annealing at 59°C for 60 s, and extension at 72°C for 60 s; and a final extension step at 72°C for 10 min.
Statistical analysis
The demographic, lifestyle, and clinical data as well as genotype distributions between gastric cancer patients and control subjects were analyzed by chi-square test. The goodness-of-fit c 2 -test was used to analyze whether the genotype distribution of IL-10 C819T deviated from the Hardy-Weinberg equilibrium (HWE). The association between demographic, lifestyle, and clinical characteristics and the development of gastric cancer was estimated by univariate logistic regression analysis. Unconditional regression analysis was used to analyze the association between the IL-10 C819T polymorphism and risk of gastric cancer. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to describe the results. The statistical analysis was conducted by the SPSS 17.0 statistical software (SPSS, Chicago, IL, USA).
RESULTS
The demographic and clinical characteristics of gastric cancer patients and control subjects are described in Table 1 . Compared with the controls, patients with gastric cancer were more likely to be male (OR = 1.53; 95%CI = 1.00-2.36), be older (OR = 1.57; 95%CI = 1.03-2.40), have a higher BMI (OR = 1.96; 95%CI = 1.15-3.34), have a habit of alcohol consumption (OR = 1.69; 95%CI = 1.11-2.58), and suffer from H. pylori infection (OR = 1.97; 95%CI = 1.29-3.01). However, no significant difference was identified between gastric cancer patients and control subjects in terms of tobacco smoking and family history of cancer. Of 157 patients with gastric cancer, 73 (46.50%) of them were at TNM stage I-II, 84 (53.50%) were at TNM stage III-IV, 82 (52.23%) were intestinal type, and 75 (47.77%) were diffuse type. The number of CC, CT, and TT genotypes of IL-10 C819T were 38 (24.20%), 83 (52.87%), and 36 (22.93%) in gastric cancer patients, respectively. The number of CC, CT, and TT genotypes of IL-10 C819T were 85 (34.14%), 127 (51.00%), and 36 (14.46%) in control subjects, respectively (Table 2) . By the c 2 -test, there was a significant difference between genotype distributions of IL-10 C819T in gastric cancer patients and controls (c 2 = 7.09; P = 0.03). By chi-square test, the genotype distributions of IL-10 C819T did not deviate from the HWE in gastric cancer patients and control subjects, and the P values were 0.47 and 0.30, respectively. By unconditional logistic regression analysis, the TT genotype of IL-10 C819T was significantly associated with increased risk of gastric cancer when compared with the CC genotype (OR = 2.24; 95%CI = 1.17-4.26; P = 0.008) ( Table 3) . In a dominant model, we found that the CT + TT genotype of IL-10 C819T was associated with susceptibility to gastric cancer compared to the CC genotype (OR = 1.63; 95%CI = 1.02-2.64; P = 0.03). In a recessive model, the TT genotype of IL-10 C819T was correlated with a higher risk of gastric cancer when compared with the CC + CT genotype (OR = 1.75; 95%CI = 1.01-3.02; P = 0.03).
1 Adjusted for age, gender, BMI, alcohol consumption, and Helicobacter pylori infection. 
DISCUSSION
We conducted a case-control study to investigate the association between the IL-10 C819T polymorphism and development of gastric cancer, and we found that the TT genotype of IL-10 C819T was associated with susceptibility to gastric cancer.
The IL-10 gene has a key role in regulating the complex network of reactions in the process of carcinogenesis. The level of IL-10 gene production is associated with autoimmunity, transplantation tolerance, and carcinogenesis. Functional polymorphisms of IL-10 could alter the anti-inflammatory process. Previous studies have investigated the association between the IL-10 C819T polymorphism and development of several kinds of cancers, such as breast cancer, prostate cancer, acute myeloid leukemia, lung cancer, and esophageal cancer (Kong et al., 2010; Liu et al., 2010; Yao et al., 2013; Yang and Fa, 2015; Zhang et al., 2015) . Kong et al. (2010) conducted a study in a Chinese population and suggested that there was no association between the IL-10 C819T polymorphism and risk of breast cancer. Liu et al. (2010) identified the role of three SNPs in the promoter of IL-10 in the risk of prostate cancer, and they reported that IL-10 C819T was not a risk factor for prostate cancer. Yao et al. (2013) reported that the IL-10 C819T site was associated with acute myeloid leukemia in a Chinese population. Zhang et al. (2015) performed a case-control study with 330 lung cancer patients and 336 cancer free controls and reported that the IL-10 C819T polymorphism is a molecular marker for lung cancer susceptibility. Yang and Fa (2015) did not suggest a significant association between the IL-10 C819T polymorphism and susceptibility to esophageal cancer.
Previous studies have reported the association between the IL-10 C819T polymorphism and development of gastric cancer, but the results are inconclusive (Kamangar et al., 2006; Sugimoto et al., 2007; Xiao et al., 2009; Sun et al., 2010; Liu et al., 2011; Xue et al., 2012; Zeng et al., 2012) . Several studies suggested that the IL-10 C819T polymorphism was associated with an increased risk of gastric cancer in Japanese and Chinese populations (Sugimoto et al., 2007; Sun et al., 2010; Xue et al., 2012; Zeng et al., 2012) . However, some studies did not find a significant role for the IL-10 C819T polymorphism in susceptibility to gastric cancer (Kamangar et al., 2006; Xiao et al., 2009; Liu et al., 2011) . In our study, we found that IL-10 C819T was correlated with the development of gastric cancer, and the results of our study are in line with the results of previous studies.
In conclusion, our study suggests that the IL-10 C819T polymorphism is associated with an increased risk of gastric cancer in co-dominant, dominant, and recessive models. Further studies with larger sample sizes are greatly needed to confirm our findings.
